Medtronic plc (MDT)
NYSE · Price as of · Nasdaq Real Time Price
- Analysts25
- Implied upside+11.6%
- Target range$78.00 to $121.00
- EPS expected$1.33 -2.2%
- A year ago$1.36
- Revenue expected$9.48B +5.8%
- Estimate range$1.32 to $1.34
How Congress has done in MDT
Every purchase of MDT disclosed by a member of Congress in the last 5 years, scored over the 12 months after the trade date against SPY over the same window.
| Measure | MDT | SPY |
|---|---|---|
| Median 12-month return after purchase | -6.9% | +18.0% |
| Median difference vs SPY | -19.5% | — |
| Purchases that beat SPY | 0 of 11 (0%) | — |
| Members who bought | 8 | — |
Most frequent buyers: Daniel Goldman (2), Rob Bresnahan (2), Scott Franklin (2), Greg Stanton (1), Jared Moskowitz (1).
These are not returns anyone actually earned. Disclosures report a dollar bracket and no share count, so every purchase is counted once and weighted equally, and sales are not matched back to the buys that opened them. 2 of the 11 purchases are disclosed as a spouse's or dependent's rather than the member's own. Purchases from the last 12 months are excluded because their window has not closed yet.
Congress trades
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-08-24 | Kevin Hern OK | Sale | $15,001 - $50,000 | |
| 2026-07-30 | Rich McCormick | Sale | $1,001 - $15,000 | |
| 2025-05-07 | Julie Johnson TX | Sale | $1,001 - $15,000 | |
| 2024-08-26 | Tommy Tuberville AL | Sale | $15,001 - $50,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 8-K | September 1, 2026 | 8-K |
| 4 | August 24, 2026 | FORM 4 |
| ARS | August 24, 2026 | ARS |
| DEFA14A | August 17, 2026 | DEFA14A |
| DEF 14A | August 17, 2026 | DEF 14A |
| 4 | August 4, 2026 | FORM 4 |
| 4 | August 4, 2026 | FORM 4 |
| 4 | August 4, 2026 | FORM 4 |
Articles that mention Medtronic without it being the main subject.
Frequently asked questions
When does MDT report earnings?
Medtronic plc (MDT) is scheduled to report quarterly results on November 17, 2026 (estimated). The 20-analyst consensus is $1.33 per share on revenue of $9.48B for the quarter ending October 31, 2026, against $1.36 and $8.96B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters. The date is an estimate from past reporting patterns and can move until the company confirms it.
What do analysts expect for MDT?
25 analysts cover Medtronic plc (MDT). The consensus rating is Buy. The average price target is $102.88, in a range of $78.00 to $121.00.
Are insiders buying or selling MDT?
We have no qualifying Form 4 insider purchases or sales on record for Medtronic plc (MDT). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Has Congress made money trading MDT?
8 members of Congress have disclosed buying MDT in the last 5 years, 11 purchases in total. Measured over the 12 months after each trade date, the median purchase returned -6.9% against +18.0% for SPY over the same windows, and 0 of the 11 (0%) beat the index. These are not returns anyone actually earned: congressional disclosures report a dollar bracket and no share count, so each purchase is counted once and weighted equally, and later sales are not matched back to the buys that opened them.
Where can I see MDT SEC filings?
Recent filings are listed on this page, newest first. The latest is an 8-K filed September 1, 2026.